In the MOMENTUM trial, which treated migraine of moderate and severe pain intensity, Symbravo showed a statistically significantly greater percentage of patients achieving pain freedom and freedom ...

phonophobia, nausea) two hours after dosing versus placebo, with benefits of pain freedom sustained through 24 and 48 hours for many patients. In the INTERCEPT trial, which treated migraine when ...

Please log in, or sign up for a new account and purchase a subscription to continue reading. BEST VALUE! Like never before, the News-Argus delivers real value every ...